Switch to: References

Citations of:

Enhancement technologies and inequality

Proceedings of the IX Conference of the Spanish Society of Logic, Methodology and Philosophy of Science (2018)

Add citations

You must login to add citations.
  1. Experimental philosophy of medicine and the concepts of health and disease.Walter Veit - 2020 - Theoretical Medicine and Bioethics 42 (3):169-186.
    If one had to identify the biggest change within the philosophical tradition in the twenty-first century, it would certainly be the rapid rise of experimental philosophy to address differences in intuitions about concepts. It is, therefore, surprising that the philosophy of medicine has so far not drawn on the tools of experimental philosophy in the context of a particular conceptual debate that has overshadowed all others in the field: the long-standing dispute between so-called naturalists and normativists about the concepts of (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   7 citations  
  • Biological normativity: a new hope for naturalism?Walter Veit - 2021 - Medicine, Health Care and Philosophy 24 (2):291-301.
    Since Boorse [Philos Sci 44(4):542–573, 1977] published his paper “Health as a theoretical concept” one of the most lively debates within philosophy of medicine has been on the question of whether health and disease are in some sense ‘objective’ and ‘value-free’ or ‘subjective’ and ‘value-laden’. Due to the apparent ‘failure’ of pure naturalist, constructivist, or normativist accounts, much in the recent literature has appealed to more conciliatory approaches or so-called ‘hybrid accounts’ of health and disease. A recent paper by Matthewson (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   17 citations  
  • Can ‘eugenics’ be defended?Francesca Minerva, Diana S. Fleischman, Peter Singer, Nicholas Agar, Jonathan Anomaly & Walter Veit - 2021 - Monash Bioethics Review 39 (1):60-67.
    In recent years, bioethical discourse around the topic of ‘genetic enhancement’ has become increasingly politicized. We fear there is too much focus on the semantic question of whether we should call particular practices and emerging bio-technologies such as CRISPR ‘eugenics’, rather than the more important question of how we should view them from the perspective of ethics and policy. Here, we address the question of whether ‘eugenics’ can be defended and how proponents and critics of enhancement should engage with each (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   7 citations